Quality & Service / UCLA Medical Group
Patient Satisfaction
 UCLA Health System is fully committed to providing our patients and their family members with the best possible experience as they visit our facilities and interact with our physicians, nurses and other clinical staff. To this end, we participate in statewide collaboratives with organizations comprised of health plans, provider organizations and purchasers. We assess our patients' experiences with the care delivered by our medical group and benchmark our performance against those of other medical groups in California. For example, results of the Patient Assessment Survey (PAS), sponsored by the California Healthcare Reporting Initiative (CCHRI), include overall rating of care and doctor-patient interaction measures. These results for commercially insured patients covered by a health maintenance organization (HMO) or point of service (POS) plan are reported in our patient satisfaction performance summary. We use this information to continually improve the experiences of the patients who entrust us with their lives.
- Overall Rating of Care
- Doctor-Patient Interactions
For information regarding how the ratings are calculated, visit the California Office of the Patient Advocate's "About Medical Group Ratings" section.
Patient Satisfaction Performance Summary
 |
For the reporting period, commercially insured HMO and POS patients rated the care provided by their UCLA primary care physician as 90 on a scale of 0 (worst care) to 100 (best care), which exceeds the average performance of medical groups in California (rated as 87). The same patients gave a rating of 85 for the overall care received at UCLA, which is equal to the statewide average of rating. UCLA's HMO/POS patients indicated they would recommend their UCLA doctor with a score of 89, which exceeds the statewide average score of 87. |
 |
For the specified reporting period, commercially insured HMO and POS patients rated their overall interactions with their UCLA primary care physician 91 on a scale of 0 (worst) to 100 (best). This exceeds the average rating of medical groups in California (89). UCLA Medical Group received high ratings (≥ 88) for all measures of doctor-patient interactions and each exceeds the California average score. |
Clinical Care
UCLA Medical Group is committed to delivering the highest quality care according to nationally recognized standards of clinical care. These standards have been established based on scientific evidence indicating that certain tests and treatment guidelines prevent development of disease, such as cancer in women, and improve outcomes for patients with chronic conditions, such as asthma, diabetes and heart disease. A statewide collaborative of health plans, provider organizations and purchasers serving approximately 94 percent of the commercially insured HMO and POS patients in California collects and publicly reports information regarding clinical care measures from participating medical groups. We use this information to continually improve the care we provide to our patients.
- Women’s Health
- Colorectal Cancer Screening
- Care for Adults
- Childhood Immunizations
- Care for Children
For information regarding how the ratings are calculated, visit the California Office of the Patient Advocate’s “About Medical Group Ratings” section.
Clinical Care Performance Summary
 |
For the specified reporting period, 79% of UCLA Medical Group's commercially insured HMO and POS female members of all ages received a mammogram to test for breast cancer during the past two years, while 87% of these patients received a pap smear to test for cervical cancer during the past three years. Approximately 55% of commercially insured HMO and POS female members received screenings for chlamydia. UCLA Medical Group's screening rates are significantly better than breast cancer (68%), cervical cancer (74%) and Chlamydia (48%) screening rates of average medical groups in California. These tests are important because with early detection, there is a much better chance that it will be treated and cured. |
| |
 |
For the specified reporting period, 69% of UCLA Medical Group's commercially insured HMO and POS members were appropriately screened for colorectal cancer according to national guidelines. This screening rate is significantly higher than the screening rates of average medical groups in California (45%). Colorectal cancer screening is important because with early detection, there is a much better chance that colorectal cancer can be effectively treated and cured. |
| |
|
 |
For the specified reporting period, 92% of UCLA Medical Group's commercially insured HMO and POS members meeting screening criteria (compared to an average of 84% statewide) had their low density lipid cholesterol (LDL) level checked in the last year after having a heart attack or surgery or for heart disease. Seventy-four percent of these patients (compared to an average of 51% statewide) had well-controlled cholesterol levels (≤100 mg/dL) after having a heart event. Lower levels of LDL cholesterol are associated with better outcomes in those with heart disease. Additionally, 85% of UCLA Medical Group patients received appropriate annual monitoring of chronic medications to manage their heart disease, compared to an average of 74% of patients statewide.
For the specified reporting period, UCLA Medical Group provide care to commercially insured HMO and POS members with diabetes that significantly exceeded the performance of average of medical groups in the state for all clinical measures. Ninety-two percent of members with diabetes had their hemoglobin A1C (HbA1C) level checked at least once in the year; 80% of these patients had well-controlled blood sugar levels; 87% of members with diabetes had their low density lipid (LDL) cholesterol level checked at least once during the year; 57% of these patients had well-controlled cholesterol levels (≤ 100 mg/dL); and 85% of members with diabetes had their kidney function tested to help manage their disease.
For the specified reporting period, 89% of UCLA Medical Group's commercially insured HMO and POS adult patients with asthma received the right medicine (anti-inflammatories) for their condition., while 55% of patients (compared to 36% statewide) were not given antibiotics for acute bronchitis. Antibiotics are not recommended for most cases of acute bronchitis. Eighty-four percent of UCLA's patients received imaging studies to diagnose their acute low back pain, which was slightly higher than the statewide average (78%).
|
|
|
 |
For the specified reporting period, commercially insured HMO and POS children treated by UCLA Medical Group received immunization shots at higher rates than the average for all children receiving care from medical groups in California. Immunizations protect children from serious diseases, such as measles, mumps, rubella and chicken pox. Medical groups that score well in this category work collaboratively with parents to ensure that their children receive these shots.
|
| |
|
 |
For the specified reporting period, 95% of commercially insured HMO and POS children with asthma aged 5 to 9 years and 97% of children with asthma aged 10 to 17 years treated by UCLA Medical Group received appropriate medicines for asthma.
For the specified reporting period, 100% of children aged 3 months to 18 years who had a simple upper respiratory infection (common cold) were not prescribed antibiotics. Antibiotics are not recommended for simple upper respiratory infections. Additionally, 65% of UCLA's patients (compared to 43% statewide) received appropriate testing for pharyngitis. UCLA Medical Group's results are significantly better than the performance of average medical groups in California.
|
|
